1219511-19-9Relevant articles and documents
HEPATITIS C INHIBITOR COMPOUNDS
-
Page/Page column 48, (2010/04/27)
Compounds of Formula (I): wherein B, R3, L0, L1, R2, Rc and R1 are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection. In particular, the present invention provides novel peptide analogs, pharmaceutical compositions containing such analogs, and uses of these analogs in the treatment of HCV infection